Flubrotizolam is a potent a novel benzodiazepine analogue. Developed for clinical purposes, flubrotizolam possesses intense anxiolytic effects. Its structural properties illustrate a high affinity for the GABA receptor, resulting significant CNS modulation. Despite its potential pharmaceutical applications, flubrotizolam's illicit use has increased